Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 6301-6310 of 11686

Edit search filters
  1. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab In Muscle Invasive Bladder Cancer

  2. A Study To Assess Myocardial Blood Flow Changes In Oncology Patients

    Rochester, MN

  3. A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer

    Jacksonville, FL

  4. A Study To Evaluate The Use Of Sublingual Tacrolimus In Adult Blood And Marrow Transplant Patients

    Rochester, MN

  5. Study Of Retinfanlimab In Combination With INCAGN02385 And INCAGN02390 As First-Line Treatment In Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck

    Jacksonville, FL

  6. A Study Of PARG Inhibitor ETX-19477 In Patients With Advanced Solid Malignancies (ERADIC8)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of An FGFR2/3 Inhibitor (CGT4859) In Patients With Cholangiocarcinoma And Other Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. AMX0035 And Progressive Supranuclear Palsy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy In Previously Treated Advanced Or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations Or Other Genomic Alterations (MK-2870-004)

    Jacksonville, FL, Rochester, MN

  10. Ivosidenib In Participants With Locally Advanced Or Metastatic Conventional Chondrosarcoma Untreated Or Previously Treated With 1 Systemic Treatment Regimen

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer